Sponsoring Organization: University of Iowa Neuroendocrine Tumor Specialized Progam of Research Excellence (SPORE) Announces Two                                                                      Funding Opportunities:                                                                                                                                                                                          (1)    2019 Developmental Research Funding Opportunity

   

Eligibility Requirements:

Letter of Concept Deadline: Friday, May 31, 2019                                                                                                                                                                                              Invited Full Proposal Deadline: Thursday, August 1, 2019                                                                                                                                                                            Anticipated Project Start Date: September 1, 2019

   
To:             Investigators interested in translational research in neuroendocrine cancers
From:       Sue O’Dorisio MD, PhD, NET SPORE Principal Investigator
                    Douglas Spitz, PhD, Director, SPORE Developmental Research Program 

Overview:

The University of Iowa Neuroendocrine Tumors Specialized Program of Research Excellence (NET SPORE) is a center grant funded through the National Cancer Institute. The mission of the NET SPORE Developmental Research Program is to encourage innovative laboratory and clinical studies in neuroendocrine tumor research, and to provide funds to support previously untested hypotheses or other innovative research objectives that address problems in neuroendocrine cancer. The project duration is one year, September 1, 2019-August 31, 2020.


Eligibility:


Investigators planning to conduct their research in universities, hospitals, research institutions, and federal agencies are eligible to apply. Applicants must hold either a PhD or MD degree or equivalent. Applicants may be of any rank including resident, fellow, associate, assistant professor, associate professor, or professor. Applicants do not need to hold a position at the University of Iowa but do need to collaborate with faculty at the University of Iowa and utilize at least one of the SPORE cores (Administration, Biospecimens, Bioinformatics/Biostatistics, Clinical Trials).


Amount of Awards:


One or two recipients will receive a maximum award of up to $50,000 per year in direct costs provided through the Iowa SPORE grant and (for University of Iowa applicants) matching institutional funds. Applicants outside of the University of Iowa note that the $50,000 includes your institution’s F&A. NIH funds must be spent by August 31, 2020. NOTE: Award is contingent on NIH funding.


Additional Information:


For additional information, please visit Cancer Research Funding Opportunities or contact Karla Stout, 319-353-8634, This email address is being protected from spambots. You need JavaScript enabled to view it. or the Developmental Research Project Director: Dr. Douglas Spitz: This email address is being protected from spambots. You need JavaScript enabled to view it. or Dr. Sue O’Dorisio This email address is being protected from spambots. You need JavaScript enabled to view it..


(2)  2019 Career Enhancement Funding Opportunity

Letter of Concept Deadline: Friday, May 31, 2019                                                                                                                                                                                                  Invited Full Proposal Deadline: Thursday, August 1, 2019                                                                                                                                                                                Anticipated Project Start Date: September 1, 2019

From: Sue O’Dorisio MD, PhD, NET SPORE Principal Investigator
James Howe, MD, Director, NET SPORE Career Enhancement Program


Overview:


The University of Iowa Neuroendocrine Tumor Specialized Program of Research Excellence (NET SPORE) is a center grant funded though the National Cancer Institute. The mission of the NET SPORE Career Enhancement Program is toward basic scientists or clinicians interested in translational research acquiring additional skills to become translational researchers in neuroendocrine tumors. The project duration is one year, September 1, 2019-August 31, 2020.


Eligibility:


This program focuses on two types of candidates:


1. Laboratory investigators at the senior post-doctoral or junior faculty level (Assistant Professor or Research Scientist) who demonstrate outstanding research potential and are interested in a career in translational neuroendocrine tumor research, but are not yet independently funded to perform this research. Experienced, successful investigators interested in shifting toward translational neuroendocrine tumor research are also eligible.


2. Clinicians who demonstrate interest and ability in translational research, are committed to careers in translational research, and wish to devote a major portion of their early faculty career to additional research training are encouraged to apply.


Amount of Award:


One or two recipients will receive a maximum award of up to $100,000 per year in direct costs provided through the Iowa NET SPORE grant and (for University of Iowa applicants) matching institutional funds for University of Iowa applicants. Applicants outside of the University of Iowa note that the $100,000 includes your institution’s F&A. NIH funds must be spent by August 31, 2020. NOTE: Award is contingent on NIH funding.


Additional Information:


For additional information, please visit Cancer Research Funding Opportunities or contact Karla Stout, 319-353-8634 or This email address is being protected from spambots. You need JavaScript enabled to view it., or the Project Director: Dr. James Howe (This email address is being protected from spambots. You need JavaScript enabled to view it.), or Dr. Sue O’Dorisio (This email address is being protected from spambots. You need JavaScript enabled to view it.)